HIV/Aids has the potential to affect our workforce, consumers and the communities in which we operate, impacting social and economic development. Reducing the prevalence of HIV/Aids is particularly important for our operations in Africa and in countries with emerging epidemics such as parts of Latin America.
Our most intensive programmes focus on regions with high HIV/Aids prevalence (more than 5% of the population). We work proactively by offering education, awareness training and treatment for all of our employees along with their spouses and immediate dependants.
As our approach to HIV/Aids is well established, we have built on the lessons we have learned to implement a broader Wellness Development Programme covering other harmful diseases such as Malaria, sexually transmitted infections, hepatitis B and C and tuberculosis.
Level assessment score
HIV/AIDSMore on our performance
HIV/Aids annual testing rate
Tests taken as a % headcount (countries with prevalence >5%)
'The fight against diseases like HIV and AIDS can only be won through effective public/private partnership.'
Global Fund Manager Resource Mobalisation Unit - Private Sector